Geary Richard S Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
59
Insider Sells Sum
$18.81M

Insider Activity of Geary Richard S

According to the SEC Form 4 filings, Geary Richard S, being in a position of

  1. EVP, Chief Development Officer at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11559 shares for $426,767,
    over all time since 2009-01-02, has bought 0 shares, and sold 449659 shares for $18.81M.

The largest sale of all time was on 2019-04-08 and amounted to 68000 shares of Ionis Pharmaceuticals, Inc. for $4.83M.

Biography of Geary Richard S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$426,7675100

Comparison of Insiders on Amount of Buys and Sells

2025-01-31SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,406
0.0009%
$32.40$45,561+1%
2025-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,072
0.0045%
$32.86$232,407+0.53%
2024-08-29SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
331
0.0002%
$49.63$16,428-28.81%
2024-08-28SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
320
0.0002%
$49.16$15,731-27.74%
2024-08-05SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
2,430
0.0017%
$48.00$116,640-22.79%
2024-02-02SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,995
0.0013%
$50.04$99,836-17.35%
2024-01-17SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,338
0.005%
$50.42$369,960-18.42%
2023-12-21SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
4,112
0.0029%
$49.29$202,681-12.97%
2023-12-20SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
6,500
0.0046%
$49.64$322,643-11.56%
2023-12-14SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
10,613
0.0074%
$49.58$526,236-14.03%
2023-02-06SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,920
0.0013%
$40.66$78,070+1.9%
2023-01-18SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,873
0.0055%
$39.57$311,525+2.76%
2021-01-13SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Offc
141
<0.0001%
$59.50$8,390-37.35%
2020-11-25SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Development
11,920
0.0085%
$50.05$596,596-22.09%
2020-11-24SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Development
2,380
0.0017%
$50.83$120,975-21.66%
2020-11-23SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Development
10,700
0.0076%
$50.11$536,177-21.85%
2019-12-04SaleIonis Pharmaceuticals, Inc.
IONS
SVP, Development
10,000
0.0071%
$65.00$650,000-15.35%
2019-12-02SaleIonis Pharmaceuticals, Inc.
IONS
SVP, Development
5,000
0.0036%
$65.06$325,287-13.8%
2019-04-08SaleIonis Pharmaceuticals, Inc.
IONS
SVP, Development
68,000
0.0401%
$71.07$4.83M-27.2%
2019-02-13SaleIonis Pharmaceuticals, Inc.
IONS
SVP, Development
1,998
0.0014%
$60.00$119,880+5.77%
Total: 59
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.